These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Thresholds for pulse wave velocity, urine albumin creatinine ratio and left ventricular mass index using SCORE, Framingham and ESH/ESC risk charts. Sehestedt T; Jeppesen J; Hansen TW; Rasmussen S; Wachtell K; Ibsen H; Torp-Pedersen C; Olsen MH J Hypertens; 2012 Oct; 30(10):1928-36. PubMed ID: 22871892 [TBL] [Abstract][Full Text] [Related]
6. Risk prediction is improved by adding markers of subclinical organ damage to SCORE. Sehestedt T; Jeppesen J; Hansen TW; Wachtell K; Ibsen H; Torp-Pedersen C; Hildebrandt P; Olsen MH Eur Heart J; 2010 Apr; 31(7):883-91. PubMed ID: 20034972 [TBL] [Abstract][Full Text] [Related]
7. Pulse wave velocity, pulse pressure and number of carotid or femoral plaques improve prediction of cardiovascular death in a population at low risk. Bérard E; Bongard V; Ruidavets JB; Amar J; Ferrières J J Hum Hypertens; 2013 Sep; 27(9):529-34. PubMed ID: 23426066 [TBL] [Abstract][Full Text] [Related]
8. Which markers of subclinical organ damage to measure in individuals with high normal blood pressure? Sehestedt T; Jeppesen J; Hansen TW; Rasmussen S; Wachtell K; Ibsen H; Torp-Pedersen C; Olsen MH J Hypertens; 2009 Jun; 27(6):1165-71. PubMed ID: 19387364 [TBL] [Abstract][Full Text] [Related]
9. Changes in subclinical organ damage vs. in Framingham risk score for assessing cardiovascular risk reduction during continued antihypertensive treatment: a LIFE substudy. Olsen MH; Wachtell K; Ibsen H; Lindholm L; Kjeldsen SE; Omvik P; Nieminen MS; Dahlöf B; Okin PM; Devereux RB J Hypertens; 2011 May; 29(5):997-1004. PubMed ID: 21358415 [TBL] [Abstract][Full Text] [Related]
10. Femoral and Carotid Subclinical Atherosclerosis Association With Risk Factors and Coronary Calcium: The AWHS Study. Laclaustra M; Casasnovas JA; Fernández-Ortiz A; Fuster V; León-Latre M; Jiménez-Borreguero LJ; Pocovi M; Hurtado-Roca Y; Ordovas JM; Jarauta E; Guallar E; Ibañez B; Civeira F J Am Coll Cardiol; 2016 Mar; 67(11):1263-74. PubMed ID: 26988945 [TBL] [Abstract][Full Text] [Related]
12. The Framingham Risk Score underestimates the extent of subclinical atherosclerosis in patients with psoriatic disease. Eder L; Chandran V; Gladman DD Ann Rheum Dis; 2014 Nov; 73(11):1990-6. PubMed ID: 23887287 [TBL] [Abstract][Full Text] [Related]
13. Value of Carotid Ultrasound in Cardiovascular Risk Stratification in Patients With Psoriatic Disease. Sobchak C; Akhtari S; Harvey P; Gladman D; Chandran V; Cook R; Eder L Arthritis Rheumatol; 2019 Oct; 71(10):1651-1659. PubMed ID: 31165591 [TBL] [Abstract][Full Text] [Related]
15. Influence of carotid atherosclerotic plaques on pulse wave assessment with arterial tonometry. Grillo A; Simon G; Salvi P; Rovina M; Baldi C; Prearo I; Bernardi S; Fabris B; Faini A; Parati G; Bardelli M; Carretta R J Hypertens; 2017 Aug; 35(8):1609-1617. PubMed ID: 28350575 [TBL] [Abstract][Full Text] [Related]
16. Arterial wall mechanical inhomogeneity detection and atherosclerotic plaque characterization using high frame rate pulse wave imaging in carotid artery disease patients in vivo. Karageorgos GM; Apostolakis IZ; Nauleau P; Gatti V; Weber R; Connolly ES; Miller EC; Konofagou EE Phys Med Biol; 2020 Jan; 65(2):025010. PubMed ID: 31746784 [TBL] [Abstract][Full Text] [Related]
17. Descriptive study of the relationship between the subclinical carotid disease and biomarkers, carotid femoral pulse wave velocity in patients with hypertension. Zhao X; Bo L; Zhao H; Li L; Zhou Y; Wang H Clin Exp Hypertens; 2018; 40(3):274-280. PubMed ID: 29227169 [TBL] [Abstract][Full Text] [Related]
18. Effect of carotid plaque screening using contrast-enhanced ultrasound on cardiovascular risk stratification. van den Oord SC; ten Kate GL; Sijbrands EJ; van der Steen AF; Schinkel AF Am J Cardiol; 2013 Mar; 111(5):754-9. PubMed ID: 23266072 [TBL] [Abstract][Full Text] [Related]
19. Low-grade albuminuria is associated with early but not late carotid atherosclerotic lesions in community-based patients with type 2 diabetes. Li MF; Tu YF; Li LX; Lu JX; Dong XH; Yu LB; Zhang R; Bao YQ; Jia WP; Hu RM Cardiovasc Diabetol; 2013 Jul; 12():110. PubMed ID: 23883448 [TBL] [Abstract][Full Text] [Related]
20. High-sensitivity C-reactive protein is only weakly related to cardiovascular damage after adjustment for traditional cardiovascular risk factors. Olsen MH; Christensen MK; Hansen TW; Gustafsson F; Rasmussen S; Wachtell K; Borch-Johnsen K; Ibsen H; Jørgensen T; Hildebrandt P J Hypertens; 2006 Apr; 24(4):655-61. PubMed ID: 16531793 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]